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indoor residual spraying in Tororo, Uganda. 
 
Joaniter I. Nankabirwa1,2, Jessica Briggs3, John Rek2, Emmanuel Arinaitwe2, Patience 
Nayebare2, Shereen Katrak3, Sarah G. Staedke4, Philip J. Rosenthal3, Isabel Rodriguez -
Barraquer 3, Moses R. Kamya1,2, Grant Dorsey3, Bryan Greenhouse3 
 
1 School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda  
2 Infectious Diseases Research Collaboration, Kampala, Uganda  
3 Department of Medicine, University of California, San Francisco, CA, USA  
4 Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, 
UK 
 
Summary: Three rounds of Indoor Residual Spraying were associated with significant 
reduction in clinical malaria and parasite prevalence, however, a proportion of the 
proportion remained parasitemic. These parasites could serve as reservoir for onward 
transmission.  
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Abstract  
Background: Indoor residual spraying of insecticide (IRS) has been associated with 
reductions in the incidence of malaria, but its impact on malaria parasitemia is unclear.  
Methods: We followed 469 participants from August 2011 to May 2016 in Tororo, Uganda, a 
historically high malaria transmission setting. Three rounds of IRS with bendiocarb were 
implemented from December 2014 to December 2015. Symptomatic malaria episodes were 
identified by passive surveillance. Parasitemia was identified by active surveillance every 1-3 
months using microscopy and P. falciparum-specific loop-mediated isothermal 
amplification. 
Results: IRS was associated with a significant decline in the incidence of symptomatic 
malaria irrespective of age (episodes per person per year reduced from 3.98 to 0.13 in 
children <5 years, 2.30 to 0.15 in children 5 – 10 years, and 0.41 to 0 in adults, p<0.001 for 
all). IRS significantly reduced the prevalence of parasitemia, however, the prevalence 
remained high (58.5% to 11.3% in children <5, 73.3% to 23.7% in children 5 – 10 years, and 
52.2% to 15.4% in adults, p<0.001 for all). 
Discussion: Although IRS was associated with significant reductions in the incidence of 
malaria and prevalence of parasitemia, a proportion of the population remained 
parasitemic, providing a potential reservoir for malaria transmission. 
 
Key words: malaria; infectious reservoir; indoor residual spraying; parasitemia  
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Introduction   
Important advances have been made in malaria control in Africa, with declines in 
malaria burden and progress towards elimination in some countries [1-3]. This progress has 
been attributed to the scale up of proven malaria control interventions including indoor 
residual spraying of insecticide (IRS), insecticide treated nets (ITNs) and effective case 
management.  IRS involves the application of long-acting insecticides on the walls of houses 
to kill mosquitoes and reduce the risk of infectious bites from the Anopheles vector. IRS has 
been used to control malaria since the 1950s [4] and has been associated in many countries 
with a significant reduction in malaria burden, including prevalence of parasitemia, 
morbidity, mortality and entomological indices of transmission [5-7]. However, although IRS 
is effective, it is difficult to maintain due to high implementation costs, and downscales have 
been reported in several countries in Africa [8].  
 
After a gap of 40 years, IRS was re-established in Uganda in 2006 in 10 districts in the 
north; an additional 14 districts were added in 2014. Use of IRS in these districts has been 
associated with a significant reduction in key malaria indicators, including the slide positivity 
rate (defined as the number of laboratory-confirmed malaria cases per 100 suspected cases 
examined), incidence of malaria, human biting rate, preterm birth risk, and prevalence of 
anemia [2, 6, 9-13]. Although significant benefits have been documented following the re-
initiation of IRS in Uganda, the observed declines in malaria burden have been temporary, 
with resurgence observed following the cessation of the intervention in Northern Uganda 
[14]. This phenomenon has been reported elsewhere; studies from many endemic settings 
show that when IRS is scaled back, there is a rapid resurgence of malaria [15]. The reason 
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for the rapidity of resurgence following cessation of IRS is not clear, however, one 
explanation could be that a significant reservoir of infections remained following the 
implementation of vector control, contributing to a rapid rebound in transmission once 
insecticide effects diminished.  
 
In highly endemic countries like Uganda, the malaria parasite reservoir is dynamic, and 
includes symptomatic and asymptomatic infections. Symptomatic infections are detected 
and treated when patients seek healthcare. Most evaluations of IRS have focused on 
measures of malaria morbidity or vector abundance [5, 7, 9, 16, 17].  Less studied are the 
effects of IRS on the prevalence of asymptomatic infections, especially low-density 
infections below the level of detection by microscopy, referred to as sub-microscopic 
parasitemia. These asymptomatic infections can only be detected by active surveillance, 
ideally using highly sensitive molecular techniques such as polymerase chain reaction (PCR) 
or loop mediated isothermal amplification (LAMP) assays. Despite the lack of attention paid 
to asymptomatic infections, these infections are known to comprise a large proportion of 
the parasitic reservoir, and recent studies have demonstrated that even low-density 
infections can transmit parasites to mosquitoes [18, 19]. It is therefore important to 
understand the impact of IRS on all parasite reservoirs (symptomatic and asymptomatic) in 
order to more effectively evaluate and direct vector control measures and determine the 
need for additional measures (such as mass drug administration) to address the parasite 
reservoir that persists after IRS.  
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In Tororo District, Uganda, 3 rounds of IRS were conducted with the carbamate 
bendiocarb between December 2014 and December 2015. Our cohort, in which participants 
were actively assessed for parasitemia every three months prior to the initiation of IRS and 
then monthly starting in December 2014, provided a unique opportunity to evaluate the 
effect of IRS on the reservoir of parasitemia in a high transmission setting. 
 
Methods 
Study setting  
The study was conducted in Nagongera sub-county, Tororo district, in southeastern 
Uganda. Tororo had high transmission of primarily Plasmodium falciparum infections, with 
an estimated entomological inoculation rate of 310 infective bites per person per year prior 
to initiation of IRS [20]. Prior to this study, malaria control in Tororo was limited to the 
distribution of ITNs through antenatal care services, promotion of intermittent preventive 
treatment during pregnancy and malaria case management with artemisinin-based 
combination therapy. One round of mass distribution of free ITNs was conducted as part of 
a national campaign in November, 2013. IRS with bendiocarb was initiated for the first time 
in Tororo District in December 2014 (December 2014-January 2015); two additional rounds 
of IRS with bendiocarb were implemented in June-July 2015 and November-December 2015.  
 
Study Design, enrolment and follow up  
Details of the cohort study have been described previously [20]. In brief, 100 
households were randomly selected using a list generated from enumeration and mapping 
of all households in Nagongera subcounty in 2011. All children aged 0.5-10 years who 
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fulfilled the selection criteria and had written informed consent from a parent or guardian 
and 1 adult primary caregiver from each household were enrolled into the cohort in August 
2011.  The cohort was dynamic, such that all newly eligible children in a household were 
enrolled, and participants who reached 11 years of age were excluded. All participants were 
given a long lasting ITN at enrollment. The enrollment visit and all subsequent study visits 
took place at a designated study clinic at Nagongera Health Center. The study clinic was 
open every day from 8:00 am to 5:00 pm for scheduled routine visits and non-routine visits 
due to illness. 
 
Routine visits were conducted at least every 90 days, and a standardized evaluation 
was conducted. Blood was collected by finger prick to perform thick and thin blood smears 
for malaria parasites and estimate hemoglobin levels; an additional sample was stored on 
filter paper for future molecular testing using LAMP. Beginning in December 2014, blood 
samples were collected every 30 days. Participants were encouraged to seek all medical 
care at the study clinic and to avoid the use of any anti-malarial medication outside of the 
clinic. Participants with fever (> 38.0°C tympanic) or history of fever in the previous 24 hours 
at the time of routine or non-routine visits had a thick blood smear read urgently. If the 
smear was positive, the patient was diagnosed with malaria and managed according to 
Uganda national guidelines (for uncomplicated malaria treatment with artemether-
lumefantrine) [21].  
 
Laboratory evaluations 
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Blood smears were stained with 2% Giemsa for 30 minutes. Parasite densities were 
calculated by counting the number of asexual parasites per 200 leukocytes (or per 500, if 
the count was less than 10 parasites per 200 leukocytes), assuming a leukocyte count of 
8,000/µl.  A thick blood smear was considered negative when the examination of 100 high 
power fields revealed no parasites. When malaria was diagnosed, thin smears were read for 
species identification based on standard morphology criteria. For quality control, all slides 
were read by a second microscopist, and a third reader was used to settle any discrepant 
readings. 
 
LAMP assays were performed on DNA from dried blood spots of all participants who 
had a negative blood smear during a routine visit in order to detect sub-microscopic 
infections. DNA was extracted using the Chelex extraction method as previously described 
[22]. LAMP was performed using Eiken LoopampTM MALARIA Pan Detection Kit reaction 
tubes and 15 µL of extracted DNA, per manufacturer’s guidelines. For each assay, 46 
samples plus one positive and one negative control were run.  The LAMP results were read 
based on visual detection of fluorescence under an ultraviolet lamp. 
 
Data analysis 
  Statistical data analysis was conducted using STATA version 14.  Baseline 
characteristics were summarized using proportions. The primary exposure of interest was 
calendar time in relationship to the implementation of IRS. The pre-IRS period was August 
2011 to January 2015, and the post-IRS periods were February 2015 – June 2015 (post 1st 
round), July 2015 to November 2015 (post 2nd round), and December 2015 – May 2016 (post 
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3rd round).  The date that IRS was considered potentially protective against malaria infection 
was 30 days after initiation of spraying. 
  
The outcomes of interest were malaria incidence and prevalence of parasitemia. 
Incidence of malaria was defined as number of symptomatic malaria episodes per time at 
risk. The prevalence of microscopic parasitemia was defined as the number of participant 
visits with a positive blood smear divided by the number of routine blood smears 
performed. The prevalence of any parasitemia was defined as the number of participant 
visits with a positive blood smear or LAMP test divided by the total number of routine blood 
smears performed. All data were stratified by three age groups a priori; 0.5 - < 5 years, 5-10 
years, and 18 years or older. Negative binomial regression models were used to calculate 
incidence rate ratios (IRR) comparing each post-IRS time period to the pre-IRS period. 
Comparisons of proportions with repeated measures were made with generalized 
estimating equations, with the use of log-binomial regression and robust standard errors to 
generate prevalence ratios (PR). A p-value < 0.05 was considered statistically significant for 
all analyses.  
 
Results 
Characteristics of the study population 
Between August 2011 and May 2016, a total of 469 participants were enrolled in the 
cohort (Table 1). The majority of the participants were children aged 5 – 10 years, and most 
(94.9%) were enrolled between August 2011 and January 2015, prior to initiation of IRS. Of 
the enrolled participants, 152 (32.6%) were withdrawn or lost to follow up. The commonest 
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiy628/5154846 by guest on 02 N
ovem
ber 2018
Ac
ce
pte
d M
an
us
cri
pt
 
10 
 
reason for leaving the study was reaching 11 years of age (74, 48.4%) which was an 
exclusion criterion. Other reasons for leaving the study included participants missing a visit 
for more than 120 days (18.4%), withdrawal of consent (12.5%), relocation out of the study 
area (11.2%), failure to comply with study procedures (7.9%) and death (1.3%). The total 
follow-up time was 1604 person-years (PY), with the majority of the follow-up time before 
the initiation of IRS (1195 PY before IRS versus 408 PY after IRS). There were 17,956 clinic 
visits within the study period, of which 8,894 (49.5%) were routine visits. At each clinic visit 
bed net use reported for the prior evening was high (99.9%). 
 
Impact of multiple rounds of IRS on incidence of malaria  
There were 2,933 episodes of symptomatic malaria over the course of the study, 
giving an overall incidence of 1.82 episodes per person per year. The majority of malaria 
episodes (93.5%) occurred prior to initiation of IRS (incidence 2.29 episodes per person per 
year versus 0.47 episodes per person per year after initiation, p<0.001). As expected, the 
incidence of malaria was highest in children under five years of age, followed by children 
five to ten years, and lowest in adults (Table 2 and Figure 1). A decline in the overall risk of 
symptomatic malaria was observed with each round of IRS, with the largest decline in 
absolute numbers of cases per person-year observed following the first round. After 3 
rounds of IRS, only 5 episodes of symptomatic malaria (0.13 episodes PPY) were reported in 
children under five years, 6 episodes in children 5 – 10 years (0.15 episodes PPY), and no 
episodes in adults.  
 
Impact of multiple rounds of IRS on the prevalence of parasitemia  
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There were 4,451 (50.4%) events of malaria parasitemia recorded at routine visits in 
the study period. The majority of these parasitemia events were asymptomatic (4,197 
[94.3%]), with more asymptomatic events detected by LAMP (2,540 [60.5%]) than 
microscopy (1,657 [39.5%]). Prior to initiation of IRS, overall prevalence of microscopic 
parasitemia was 25.6%, decreasing to 16% (P<0.001) following three rounds of IRS. The 
baseline prevalence of microscopic parasitemia was highest among children 5-10 years of 
age (37.3%) and lowest in the adults (6.1%).  As with incidence, a decline in the revalence 
of microscopic parasitemia in children was observed with each round of IRS.  Three rounds 
of IRS reduced the prevalence of microscopic parasitemia from 24% to 5.1% in children 
under 5 years, and from 37.3 % to 10.2% in children 5-10 years of age (p<0.001 for both). 
However, in adults, prevalence after the 2nd round of IRS remained similar to that before 
initiation of IRS, with an observable decrease noted only after the 3rd round (6.1% pre-IRS 
versus 2.1% post 3rd round of IRS, p=0.058) (Table 2 and Figure 2).  
 
Compared with microscopy alone, the prevalence of any parasitemia was 
approximately twice as high in children and 8-fold higher in adults prior to IRS when LAMP 
results were included. The majority of infections were sub-microscopic in children under 5 
years (59%) and in adults (88.3%), and nearly half of infections (48.1%) were sub-
microscopic in children 5 – 10 years. As observed with microscopic parasitemia, there was a 
significant reduction in parasite prevalence with each successive round of IRS in children 
(Table 2, Figure 3). However, in adults, in contrast to the results for microscopic parasitemia, 
one round of IRS was sufficient to significantly reduce the prevalence of parasitemia 
detected by microscopy and LAMP (Prevalence Ratio (PR 0.72, 95% CI 0.58 – 0.88 p=0.001). 
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Critically, though 3 rounds of IRS significantly reduced parasitemia across all age groups, 
residual parasite prevalence after 3 rounds remained quite high, especially in children 5-10 
years (23.7%) and adults (14.8%). After 3 rounds of IRS, sub-microscopic parasitemia 
accounted for the majority of parasitemia in all age groups (56.8% in children under 5, 
56.7% in children 5-10, and 85.7% in adults).  There was a rebound in symptomatic malaria 
and to a lesser degree in parasitemia prevalence (both microscopic and all parasitemia) 
after the first and second rounds of IRS, but not after the third round (Figures 1, 2 and 3). 
The overall prevalence of gametocytes was very low (273, 2. 9%), with the majority of 
gametocytes seen prior to initiation of IRS (182/273, 66.7%).  There was a significant 
reduction in the overall prevalence of gametocytes following 3 rounds of IRS (PR=0.76, 95% 
CI 0.59 – 0.97, p=0.02). 
 
Discussion 
We investigated the impact of multiple rounds of IRS on the incidence of malaria and 
prevalence of parasitemia, and how the impact varied with age in order to better 
characterize the parasite reservoir available to contribute to transmission. IRS significantly 
reduced both the incidence of symptomatic malaria and the prevalence of parasitemia; 
however, a large proportion of the population remained parasitemic even after 3 
consecutive rounds of IRS. Notably, the majority of this residual parasite reservoir was sub-
microscopic in all age groups. 
 
Although significant progress has been realized in the last decade, the 2017 World 
Malaria Report suggested that the decline in malaria burden has stalled [1]. Indeed, current 
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiy628/5154846 by guest on 02 N
ovem
ber 2018
Ac
ce
pte
d M
an
us
cri
pt
 
13 
 
control strategies are unlikely to be sufficient to eliminate malaria in many countries, 
prompting calls for innovation in developing new control tools and in using available 
methods in novel ways.  IRS has long been documented to reduce the malaria burden and 
improve entomological outcomes; however, its benefits are typically short-lived, as it is too 
expensive to continue indefinitely [14]. To our knowledge, the effect of IRS on the different 
reservoirs of malaria parasites has not previously been reported. Because parasitemic 
individuals may serve as a reservoir for transmission, particularly if IRS is delayed, 
interrupted, or discontinued, it is vitally important to better characterize this reservoir. 
Notably, similar to results from other studies [9, 16, 23-25], in our cohort 3 rounds of IRS 
provided almost total protection against symptomatic malaria, irrespective of age group.  
 
Unlike previous studies, our study explored the longitudinal impact of multiple rounds 
of IRS on all parasitemia. Intriguingly, at baseline (pre-IRS), adults had a prevalence of all 
parasitemia that was nearly as high as that of children under the age of 5 (52.2% vs 58.5% 
respectively), primarily due to sub-microscopic infections.  Thus, though compared to 
children adults have lower density infections and are less likely to become symptomatic, 
they represent a large portion of the reservoir of malaria parasitemia. Therefore, 
surveillance for sub-microscopic infections in both children and adults is needed to fully 
understand the efficacy of malaria control interventions on transmission. 
 
Importantly, in our study the prevalence of parasitemia remained high even after 3 
rounds of IRS, especially in older children and adults. A possible explanation for why we 
observed a less pronounced drop in prevalence versus incidence is because IRS likely 
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decreases the rate of acquisition of new infections, which are most likely to cause 
symptoms, without impact on existing blood stage infections, which may last for a year or 
longer [23]. In addition, reduction of malaria incidence after IRS will lead to fewer courses of 
treatment so that the average duration of infection may increase. Thus, the residual 
reservoir following IRS may represent infections which are on average older and less 
dynamic than those prior to IRS. If this is true, targeting this reservoir directly, for example 
via administration of antimalarials, may hasten reductions in incidence and prevalence and 
make these gains more robust despite delays, temporary interruptions, or otherwise 
decreased efficacy of vector control. 
 
Previous studies have shown that asymptomatic infections may be responsible for the 
majority of onward mosquito infections, especially following control efforts [24]. Studies 
have also shown that though older children and adults transmit fewer parasites to 
mosquitoes than young children, they receive more mosquito bites, and are thus are likely 
to contribute equally or more to transmission [25]. In our high transmission setting, 3 
rounds of IRS were highly effective in reducing morbidity but did not eliminate the 
infectious reservoir, and a large proportion of this reservoir was composed of older children 
and adults. These study findings may help explain the rapidity of resurgence of malaria 
following the withdrawal of IRS observed in Northern Uganda [16, 17] and elsewhere. The 
findings highlight that combination of IRS with other effective interventions, e.g. integrated 
vector control [26] and/or chemoprevention [27], is likely to bring us closer to the goal of 
eliminating the infectious reservoir. 
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  Limitations to our study included the observational study design and lack of a control 
group. However, it is likely that the observed changes in malaria incidence and parasitemia 
were related to the initiation of IRS given the longitudinal nature of the data and the timing 
and magnitude of changes [6]. Another limitation was the use of LAMP to assess for sub-
microscopic parasitemia; a recent study showed that LAMP failed to identify more than half 
of all infections diagnosed by ultra-sensitive qPCR [28]. Thus, we likely missed a proportion 
of very low-density infections, and so the true prevalence of submicroscopic parasitemia 
after multiple rounds of IRS is likely to be even higher than observed in our study. Finally, 
we were unable to tell whether the infections remaining after IRS were new or old 
infections; this would require genotyping these infections, which was beyond the scope of 
this work. 
 
Our study highlights the need to include molecular diagnostics in epidemiological 
studies of malaria, as a substantial proportion of malaria infections are undetected by 
conventional microscopy and rapid diagnostic tests. Our current understanding of the 
importance of sub-microscopic infections for malaria transmission is incomplete, and the 
longitudinal dynamics of these infections need to be further characterized, especially in the 
context of ongoing malaria control interventions, so that the use of these interventions can 
be optimized.  
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Table 1. Characteristics of the study population 
Characteristic 
Before IRS  
(Aug 2011- Jan 2015) 
After 1st round of IRS  
(Feb 2015 - Jun 2015) 
After 2nd round of IRS 
(Jul 2015 - Nov 2015) 
After 3rd round of IRS 
(Dec 2015 - May 2016) 
Data at the participant level 
Number of participants         
  0.5 - <5 years 192 80 79 82 
   5 - 10 years 148 179 168 161 
   >18 years 106 80 77 74 
Total follow up time (person-years)     
  0.5 - <5 years 345.7 29.4 29.5 37.5 
   5 - 10 years 539.2 69.2 66.7 75.4 
   >18 years 310.3 32.6 31.6 36.6 
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Data at the visit level 
Type of visit, n (%)     
   Enrollment 445 (3.5) 5 (0.3) 14 (0.9) 5 (0.3) 
   Unscheduled  7,790 (60.1) 460 (26.5) 496 (30.1) 316 (19.6) 
   Routine 4,725 (36.5) 1,270 (73.2) 1,139 (69.1) 1,291 (80.1) 
Febrile during study visit, n (%) 3,094 (40.7) 155 (11.2) 67 (5.6) 30 (2.3) 
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Table 2. Incidence of malaria and prevalence of parasitemia before and after implementation of IRS stratified by age of the participants 
Time period
 a
 
Age group 
Children 0.5 - <5 years Children 5 – 10 years Adults 18 years and above 
 
Incidence 
PPY 
Incident rate ratio 
 (95%CI) 
p-value 
Incidence 
PPY 
Incident rate ratio 
(95%CI) 
p-value 
Incidence 
PPY 
Incident rate ratio 
(95%CI) 
p-value 
Clinical Malaria 
Pre-IRS 3.98 1  2.30 1  0.41 1  
After 1
st
 round of IRS 1.37 0.29 (0.20 – 0.41) <0.001 1.15 0.31 (0.24 – 0.40) <0.001 0.22 0.63 (0.28 – 1.46) 0.295 
After 2
nd
 round of IRS 0.41 0.10 (0.05 – 0.18) <0.001 0.48 0.13 (0.09 – 0.19) <0.001 0.13 0.36 (0.12 – 1.06) 0.064 
After 3
rd
 round of IRS 0.13 0.04 (0.02 – 0.10) <0.001 0.15 0.04 (0.02 – 0.08) <0.001 0 0 (n/a) n/a 
 Parasite 
Prevalence (n) 
Prevalence Ratio 
(95%CI) 
p-value 
Parasite 
Prevalence(n) 
Prevalence Ratio 
(95%CI) 
p-value 
Parasite 
Prevalence (n) 
Prevalence Ratio 
(95%CI) 
p-value 
Microscopic parasitemia
 b
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Pre-IRS  24.0% (366) 1  37.3% (878) 1  6.1% (78) 1  
Post 1
st
 round of IRS 13.3% (45) 0.7 (0.5 – 0.8) 0.001 30.9% (240) 0.8 (0.8 – 0.9) 0.004 9.6% (15) 1.6 (0.9 – 2.8) 0.073 
Post 2
nd
 round of IRS 10.5% (31) 0.5 (0.4 – 0.7) <0.001 20.9% (148) 0.6 (0.5 – 0.7) <0.001 7.2% (10) 1.2 (0.6 – 2.2) 0.624 
Post 3
rd
 round of IRS 5.1% (17) 0.3 (0.2 – 0.4) <0.001 10.2% (82) 0.3 (0.2 – 0.3) <0.001 2.1% (3) 0.3 (0.1 – 1.0) 0.058 
Any parasitemia
 b
 
Pre-IRS 58.5% (891) 1  73.3% (1,178) 1  52.2% (666) 1  
Post 1
st
 round of IRS 26.8% (91) 0.5 (0.4 – 0.6) <0.001 51.5% (400) 0.8 (0.7 – 0.8) <0.001 37.8% (59) 0.7 (0.6 – 0.9) 0.001 
Post 2
nd
 round of IRS 19.6% (58) 0.4 (0.3 – 0.5) <0.001 39.2% (278) 0.6 (0.5 – 0.6) <0.001 24.5% (34) 0.5 (0.4 – 0.6) <0.001 
Post 3
rd
 round of IRS 11.3% (38) 0.3 (0.2 – 0.3) <0.001 23.7% (187) 0.4 (0.3 – 0.4) <0.001 15.4% (22) 0.3 (0.2 – 0.4) <0.001 
a 
The periods for Pre-IRS period is August 2011- January 2015, 1
st
 round of IRS is February – June 15, 2
nd
 Round of IRS is July – November 2015, 3rd round of IRS is December 2015 – 
May 2016.   
b 
Only includes enrollment and routine visits. 
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Figure legend 
Figure 1: Temporal changes in the incidence of malaria stratified by age. Monthly trends of 
the incidence of clinical malaria following multiple rounds of IRS with the carbamate 
bendiocarb (pink bars). 
 
Figure 2: Temporal changes in the prevalence of microscopic parasitemia stratified by age.  
Monthly trends of microscopic parasitemia following multiple rounds of IRS with the 
carbamate bendiocarb (pink bars) 
 
Figure 3: Temporal changes in the prevalence of any parasitemia (microscopic and sub-
microscopic) stratified by age. Monthly trends of microscopic and sub-microscopic 
parasitemia following multiple rounds of IRS with the carbamate bendiocarb (pink bars). 
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Figure 1 
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Figure 2 
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Figure 3 
 
 
 
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiy628/5154846 by guest on 02 N
ovem
ber 2018
